Article
Overexpression of transforming growth factor beta type I receptor abolishes malignant phenotype of a rat bladder carcinoma cell line.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research - 1 Aug 1997
Okamoto M, Oyasu R
Abstract excerpt
Transforming growth factor beta1 (TGF-beta1), a potent growth inhibitor of bladder carcinoma cells, elicits its effects by binding to cell surface receptors. LMC19, a highly invasive and metastatic rat bladder carcinoma cell line, was insensitive to the growth-suppressive effect of TGF-beta1, and it expressed undetectable levels of TGF-beta type I receptor (TbetaRI) mRNA by reverse transcription-PCR and its...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
